Sandra Torres1,2, Marta Camacho3, Patrício Costa1,4,5, Gabriela Ribeiro3,6, Osvaldo Santos7,8, Filipa Mucha Vieira1, Isabel Brandão9,10, Daniel Sampaio11,12, Albino J Oliveira-Maia13,14,15,16. 1. Faculdade de Psicologia e de Ciências da Educação, Universidade do Porto, Rua Alfredo Allen, 4200-135, Porto, Portugal. 2. Center for Psychology, Universidade do Porto, Rua Alfredo Allen, 4200-135, Porto, Portugal. 3. Champalimaud Clinical Centre, Champalimaud Centre for the Unknown, Avenida de Brasília, Doca de Pedrouços, 1400-038, Lisbon, Portugal. 4. Life and Health Sciences Research Institute (ICVS), Escola de Ciências da Saúde, Universidade do Minho, Campus de Gualtar, 4710-057, Braga, Portugal. 5. ICVS/3B's, PT Government Associate Laboratory, Campus de Gualtar, 4710-057, Braga, Portugal. 6. Lisbon Academic Medical Centre, Faculdade de Medicina da Universidade de Lisboa, Avenida Prof. Egas Moniz, 1649-028, Lisbon, Portugal. 7. Instituto de Medicina Preventiva e Saúde Pública, Faculdade de Medicina da Universidade de Lisboa, Avenida Prof. Egas Moniz, 1649-028, Lisbon, Portugal. 8. Instituto de Saúde Ambiental, Faculdade de Medicina da Universidade de Lisboa, Avenida Prof. Egas Moniz, 1649-028, Lisbon, Portugal. 9. Department of Psychiatry, Centro Hospitalar de S. João, Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal. 10. Faculdade de Medicina da Universidade do Porto, Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal. 11. Department of Psychiatry, Centro Hospitalar de Lisboa Norte, Avenida Prof. Egas Moniz, 1649-035, Lisbon, Portugal. 12. Department of Psychiatry, Faculdade de Medicina da Universidade de Lisboa, Avenida Prof. Egas Moniz, 1649-028, Lisbon, Portugal. 13. Champalimaud Clinical Centre, Champalimaud Centre for the Unknown, Avenida de Brasília, Doca de Pedrouços, 1400-038, Lisbon, Portugal. albino.maia@neuro.fchampalimaud.org. 14. Department of Psychiatry and Mental Health, Centro Hospitalar de Lisboa Ocidental, Rua da Junqueira, 1349-019, Lisbon, Portugal. albino.maia@neuro.fchampalimaud.org. 15. NOVA School of Medicine | Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Campo dos Mártires da Pátria, 1169-056, Lisbon, Portugal. albino.maia@neuro.fchampalimaud.org. 16. Champalimaud Research, Champalimaud Centre for the Unknown, Avenida de Brasília, Doca de Pedrouços, 1400-038, Lisbon, Portugal. albino.maia@neuro.fchampalimaud.org.
Abstract
PURPOSE: Rising rates of obesity have been recently associated to the novel concept of food addiction (FA). The Yale Food Addiction Scale (YFAS) is the most widely used measure for examining FA (1) and analysis of its reliability and validity is expected to facilitate empirical research on the construct. Here, we tested the psychometric properties of a Portuguese version of the YFAS (P-YFAS), establishing its factor structure, reliability and construct validity. METHODS: Data were obtained from 468 Portuguese individuals, 278 sampled from non-clinical populations, and 190 among obese candidates for weight-loss surgery. A battery of self-report measures of eating behavior was applied. RESULTS: Confirmatory factor analysis verified a one-factor structure with acceptable fit, with item analysis suggesting the need to eliminate item 24 from the P-YFAS. Internal consistency (KR-20 = .82) and test-retest stability were adequate. Correlation analyses supported convergent and divergent validity of the P-YFAS, particularly in the clinical sample. Both FA symptom count and diagnosis, according to the P-YFAS, adequately discriminated between samples, with classification of FA met by 2.5 and 25.8% of the participants in the non-clinical and clinical samples, respectively. CONCLUSIONS: These findings reinforce the use of P-YFAS in non-clinical and clinical populations. Future directions for extending YFAS validation are discussed.
PURPOSE: Rising rates of obesity have been recently associated to the novel concept of food addiction (FA). The Yale Food Addiction Scale (YFAS) is the most widely used measure for examining FA (1) and analysis of its reliability and validity is expected to facilitate empirical research on the construct. Here, we tested the psychometric properties of a Portuguese version of the YFAS (P-YFAS), establishing its factor structure, reliability and construct validity. METHODS: Data were obtained from 468 Portuguese individuals, 278 sampled from non-clinical populations, and 190 among obese candidates for weight-loss surgery. A battery of self-report measures of eating behavior was applied. RESULTS: Confirmatory factor analysis verified a one-factor structure with acceptable fit, with item analysis suggesting the need to eliminate item 24 from the P-YFAS. Internal consistency (KR-20 = .82) and test-retest stability were adequate. Correlation analyses supported convergent and divergent validity of the P-YFAS, particularly in the clinical sample. Both FA symptom count and diagnosis, according to the P-YFAS, adequately discriminated between samples, with classification of FA met by 2.5 and 25.8% of the participants in the non-clinical and clinical samples, respectively. CONCLUSIONS: These findings reinforce the use of P-YFAS in non-clinical and clinical populations. Future directions for extending YFAS validation are discussed.
Authors: Michael R Lowe; Meghan L Butryn; Elizabeth R Didie; Rachel A Annunziato; J Graham Thomas; Canice E Crerand; Christopher N Ochner; Maria C Coletta; Dara Bellace; Matthew Wallaert; Jason Halford Journal: Appetite Date: 2009-06-12 Impact factor: 3.868
Authors: Pardis Pedram; Danny Wadden; Peyvand Amini; Wayne Gulliver; Edward Randell; Farrell Cahill; Sudesh Vasdev; Alan Goodridge; Jacqueline C Carter; Guangju Zhai; Yunqi Ji; Guang Sun Journal: PLoS One Date: 2013-09-04 Impact factor: 3.240
Authors: Ligia de Oliveira Carlos; Marilia Rizzon Zaparolli Ramos; Nathalia Ramori Farinha Wagner; Lineu Alberto Cavazani de Freitas; Ingrid Felicidade; Antonio Carlos Ligocki Campos Journal: Arq Bras Cir Dig Date: 2022-06-24
Authors: Paulo R Nunes-Neto; Cristiano A Köhler; Felipe B Schuch; João Quevedo; Marco Solmi; Andrea Murru; Eduard Vieta; Michael Maes; Brendon Stubbs; André F Carvalho Journal: Braz J Psychiatry Date: 2018-06-11 Impact factor: 2.697